ARCHIVES

In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested

This article is from The Cancer Letter archive.

Vol. 05 No. 35 | August 31, 1979

Download PDF Visit The Full Archive

Related Articles

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

Horvitz Wins BMS Award In Neuroscience; Group Room To Discuss Congressional Issues.

February 22, 2002

In Brief: Winston Ho Heads Saint Joseph Bone Marrow Transplant Unit; Smoking Cost $452 Bil. A Year

March 16, 1990

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005